These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30444747)

  • 101. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. I. Characteristics of the tumours and details of the procedure.
    Lindgren G; Lindblom B; Bratel AT; Mölne L; Larkö O
    Acta Ophthalmol Scand; 2000 Aug; 78(4):425-9. PubMed ID: 10990045
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The Role of Surgery After Remission of Nonsystemic Extensive Periorbital Basal Cell Carcinoma Treated by Vismodegib: A Systematic Review.
    Peillex D; Passemard L; Magnin B; Rouanet J; Pham Dang N
    Dermatol Surg; 2022 Sep; 48(9):905-911. PubMed ID: 36054041
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Clinical efficacy of Mohs surgery combined with topical photodynamic therapy for facial basal cell carcinoma.
    Zhang J; Lu Y; Zhang X; Yang Y; Kou H; Wang Y
    J Cancer Res Ther; 2020 Sep; 16(5):1051-1055. PubMed ID: 33004746
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Basal cell carcinoma--new aspects of diagnosis and treatment.
    Wennberg AM
    Acta Derm Venereol Suppl (Stockh); 2000; 209():5-25. PubMed ID: 10884941
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden.
    Wennberg AM; Larkö O; Stenquist B
    Acta Derm Venereol; 1999 Sep; 79(5):370-2. PubMed ID: 10494714
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease.
    Goldenberg G; Hamid O
    J Drugs Dermatol; 2013 Dec; 12(12):1369-78. PubMed ID: 24301238
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp.
    Tauber G; Pavlovsky L; Fenig E; Hodak E
    J Am Acad Dermatol; 2015 Nov; 73(5):799-801. PubMed ID: 26320385
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Vismodegib: A Review in Advanced Basal Cell Carcinoma.
    Frampton JE; Basset-Séguin N
    Drugs; 2018 Jul; 78(11):1145-1156. PubMed ID: 30030732
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas.
    Kis EG; Baltás E; Ócsai H; Vass A; Németh IB; Varga E; Oláh J; Kemény L; Tóth-Molnár E
    Sci Rep; 2019 Mar; 9(1):4285. PubMed ID: 30862897
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Advanced periocular basal cell carcinoma-a therapeutic challenge].
    Lauterbach B; Kakkassery V; Debus D; Heindl LM; Schultz ES
    Ophthalmologe; 2019 Mar; 116(3):273-277. PubMed ID: 29777299
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
    Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
    Català A; Garces JR; Alegre M; Gich IJ; Puig L
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Vismodegib for basal cell carcinoma: targeted therapy in case of locally advanced or metastasised disease].
    Reinders MG; Terra JB; Reyners AK; Aarts MJ; de Haas ER; Mosterd K
    Ned Tijdschr Geneeskd; 2016; 160():D187. PubMed ID: 28000572
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Hyperbaric oxygen and Mohs micrographic surgery in the treatment of osteoradionecrosis and recurrent cutaneous carcinoma.
    Laman SD; Whitaker DC; Hoffman HH; Jebson P
    J Dermatol Surg Oncol; 1992 Jul; 18(7):579-83. PubMed ID: 1624631
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Sonic Hedgehog Pathway Blockade After Surgical Debulk of Large Exophytic Basal Cell Carcinomas.
    Wirth PJ; Hobbs R; Billingsley E; Vidimos AT; Lam C
    Dermatol Surg; 2021 Aug; 47(8):1118-1119. PubMed ID: 34107497
    [No Abstract]   [Full Text] [Related]  

  • 117. Guidelines for vismodegib in the management of periocular basal cell carcinoma.
    Hussain A; Tucker N; DeAngelis DD; Yin VT; Ing E; Arthurs B; Gill HS; Hardy I; Hurwitz J; Kratky V; Maleki B; Nijhawan N; Oestreicher J; Zafar A
    Can J Ophthalmol; 2020 Jun; 55(3):245-252. PubMed ID: 31901307
    [TBL] [Abstract][Full Text] [Related]  

  • 118. An Advanced Preoperative Mohs Micrographic Surgery Scoring System.
    Walker B; Hand M; Chesnut C
    Dermatol Surg; 2020 Feb; 46(2):270-272. PubMed ID: 30893182
    [No Abstract]   [Full Text] [Related]  

  • 119. Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series.
    Wong C; Poblete-Lopez C; Vidimos A
    J Am Acad Dermatol; 2020 Jun; 82(6):1539-1542. PubMed ID: 32092372
    [No Abstract]   [Full Text] [Related]  

  • 120. Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center.
    Ayén-Rodríguez A; Linares-González L; Llamas-Segura C; Almazán-Fernández FM; Ruiz-Villaverde R
    Int J Environ Res Public Health; 2023 May; 20(10):. PubMed ID: 37239551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.